Article Text

Download PDFPDF
Regional blood flow occlusion during extensive pelvic procedures for ovarian cancer: a randomized trial
  1. S. M. Eisenkop*,
  2. N. M. Spirtos,
  3. W. M. Lin*,
  4. F. Rafidi and
  5. G. M. Gross§
  1. * Women's Cancer Center: Encino-Tarzana, Tarzana
  2. Women's Cancer Center: Palo Alto, Palo Alto
  3. Vascular Group, Tarzana, CA
  4. § Huntsville Vascular Specialists PC, Huntsville, AL
  1. Address correspondence and reprint requests to: Scott M. Eisenkop, MD, Women's Cancer Center, 5525 Etiwanda Ave. Suite 311, Tarzana, CA 91356. Email: dobsncats{at}aol.com

Abstract

The objective of this study was to determine the effects of intraoperative aortic occlusion on blood loss and operative time when used during en bloc resection of internal reproductive organs, pelvic peritoneum, and rectosigmoid colon [modified posterior exenteration (MPE)] for primary cytoreduction of ovarian cancer. Patients undergoing MPE, without palpable distal aortic plaque or calcification, were randomized to: (a) complete distal aortic occlusion (≤60 min, with heparin and protamine reversal) with a vascular clamp immediately before MPE, (b) bilateral hypogastric artery occlusion, or (c) no regional blood flow occlusion. Outcomes were compared with respect to blood loss, operative time, and the transfusion rate (ANOVA analysis of variance). Fifty-six patients were accrued. Groups were equivalent with respect to age, disease severity, extent of upper abdominal surgery done, and cytoreductive outcomes. Aortic occlusion significantly reduced the total operative time (P = 0.02), estimated blood loss (P = 0.01), transfusion rate (P = 0.02), hospital stay (P = 0.05), and both operative time (P ≤ 0.001) and blood loss (P ≤ 0.001) specifically associated with MPE. There were no immediate or delayed complications due to aortic clamping. Aortic occlusion significantly reduces the blood loss and operative time for patients requiring MPE in the context of primary cytoreductive operations.

  • morbidity
  • ovarian cancer cytoreduction

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.